---
figid: PMC9454804__cells-11-02676-g010
figtitle: Targeting Anti-Angiogenic VEGF165b–VEGFR1 Signaling Promotes Nitric Oxide
  Independent Therapeutic Angiogenesis in Preclinical Peripheral Artery Disease Models
organisms:
- Mus musculus
- Rattus norvegicus
- Cricetulus griseus
- Homo sapiens
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC9454804
filename: cells-11-02676-g010.jpg
figlink: /pmc/articles/PMC9454804/figure/cells-11-02676-f010/
number: F10
caption: Schematic of VEGFR1 vs. VEGFR2 signaling activation by VEGF165b in ischemic
  endothelium. The left panel shows the classical VEGF165a induced VEGFR2 signaling
  pathway in ECs. The middle panel demonstrates that VEGF165b treatment induces VEGFR2-AKT-ERK
  signaling but inhibits VEGFR1-STAT3 signaling in ischemic ECs. Despite activating
  VEGFR2 signaling, the inhibition of VEGFR1 signaling resulted in angiogenic inhibition
  in ischemic ECs treated with VEGF165b. In the right panel, antibody-mediated VEGF165b
  inhibition increased the bioavailability of VEGF165a to VEGFR1 (due to its 10X higher
  binding affinity to VEGFR1 over VEGFR2) and activated VEGFR1-STAT3 signaling but
  resulted in the loss of VEGFR2 signaling activation. Activating VEGFR1-STAT3 signaling-induced
  ischemic angiogenesis independent of VEGFR2 signaling.
papertitle: Targeting Anti-Angiogenic VEGF165b–VEGFR1 Signaling Promotes Nitric Oxide
  Independent Therapeutic Angiogenesis in Preclinical Peripheral Artery Disease Models.
reftext: Sivaraman Kuppuswamy, et al. Cells. 2022 Sep;11(17):2676.
year: '2022'
doi: 10.3390/cells11172676
journal_title: Cells
journal_nlm_ta: Cells
publisher_name: MDPI
keywords: angiogenesis | anti-angiogenic VEGF-A | ischemia | growth factor signaling
  | nitric oxide | diabetes
automl_pathway: 0.8071114
figid_alias: PMC9454804__F10
figtype: Figure
redirect_from: /figures/PMC9454804__F10
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9454804__cells-11-02676-g010.html
  '@type': Dataset
  description: Schematic of VEGFR1 vs. VEGFR2 signaling activation by VEGF165b in
    ischemic endothelium. The left panel shows the classical VEGF165a induced VEGFR2
    signaling pathway in ECs. The middle panel demonstrates that VEGF165b treatment
    induces VEGFR2-AKT-ERK signaling but inhibits VEGFR1-STAT3 signaling in ischemic
    ECs. Despite activating VEGFR2 signaling, the inhibition of VEGFR1 signaling resulted
    in angiogenic inhibition in ischemic ECs treated with VEGF165b. In the right panel,
    antibody-mediated VEGF165b inhibition increased the bioavailability of VEGF165a
    to VEGFR1 (due to its 10X higher binding affinity to VEGFR1 over VEGFR2) and activated
    VEGFR1-STAT3 signaling but resulted in the loss of VEGFR2 signaling activation.
    Activating VEGFR1-STAT3 signaling-induced ischemic angiogenesis independent of
    VEGFR2 signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pik3r1
  - Akt1
  - Nos1
  - Elk3
  - Slc6a2
  - Ephb1
  - Stat3
  - Kdr
  - Ephb2
  - Mapk1
  - Vegfa
  - Vegfb
  - Pik3cg
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - NOS1
  - NOS2
  - NOS3
  - GFER
  - GJA1
  - SGSH
  - PANK2
  - ELK3
  - EPHB1
  - SLC6A2
  - STAT3
  - KDR
  - EPHB2
  - MAPK1
  - MAPK3
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Nos
  - nos
  - net
  - Neto
  - NetA
  - NetB
  - Erk7
  - rl
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
---
